Evidence map›Paper›PMID 39027895›Full record

ArticlePlastic and reconstructive surgery. Global open2024

Analyzing Google Search Trends for Migraine Surgery and Nurtec in Response to Public Announcements.

Anthony E Bishay, Arman J Fijany, Cole Holan, Ronnie N Mubang, Lisandro Montorfano, Sofia E Olsson, Thomas Troia, Arash Bakian, Salam Al Kassis, Bill V Tran

Abstract read
In one paragraph

Article in Plastic and reconstructive surgery. Global open, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Anthony E BishayFrom Vanderbilt University School of Medicine, Nashville, Tenn.
Arman J FijanyDepartment of General Surgery, Vanderbilt University Medical Center, Nashville, Tenn.
Cole HolanDepartment of Plastic Surgery, Mayo Clinic, Rochester, Minn.
Ronnie N MubangDepartment of Plastic Surgery, Vanderbilt University Medical Center, Nashville, Tenn.
Lisandro MontorfanoDepartment of Plastic Surgery, Vanderbilt University Medical Center, Nashville, Tenn.
Sofia E OlssonAnne Burnett Marion School of Medicine, Texas Christian University, Fort Worth, Tex.
Thomas TroiaAnne Burnett Marion School of Medicine, Texas Christian University, Fort Worth, Tex.
Arash BakianUniversity of Southern California, Los Angeles, Calif.
Salam Al KassisDepartment of Plastic Surgery, Vanderbilt University Medical Center, Nashville, Tenn.
Bill V TranDepartment of Plastic Surgery, Mayo Clinic, Rochester, Minn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Nurtec, a versatile migraine medication, has gained popularity. However, the awareness of migraine surgery remains uncertain. Methods: Following a descriptive approach, this cross-sectional study used Google Trends data as of December 1, 2023, to analyze internet search patterns. Approval from Vanderbilt University's institutional review board and adherence to Strengthening the Reporting of Observational Studies in Epidemiology guidelines were confirmed. Monthly relative search volume (RSV) data for "migraine surgery," "Nurtec," and "Rimegepant" were collected from January 1, 2004, to November 11, 2023, within the United States. Statistical analysis involved determining mean monthly RSV values and percentage changes for critical periods. Results: For "Nurtec," a significant surge in RSV occurred from March 2020 to April 2020 (344%). Additional peaks were observed from June 2020 to July 2020 (66%), October 2020 to December 2020 (169%), May 2021 to June 2021 (33%), and May 2023 to June 2023 (14%). "Migraine surgery" exhibited a notable 400% increase in RSV, from March 2005 to May 2005. However, post-2006, RSV for "migraine surgery" consistently remained low without noticeable peaks. Conclusions: The analysis of RSV trends for "Nurtec" and "migraine surgery" from 2004 to 2023 reveals the impact of pivotal events and marketing strategies on public interest. The distinct peaks in "Nurtec" RSV align with Food & Drug Administration approvals and marketing campaigns, highlighting the medication's accessibility. Conversely, the consistently low RSV for "migraine surgery" indicates limited awareness, emphasizing the need for enhanced promotion and education regarding surgical interventions.

Identifiers

PMID39027895
PMCPMC11257674

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.